Portside Wealth Group, LLC Astrazeneca PLC Transaction History
Portside Wealth Group, LLC
- $524 Billion
- Q2 2024
A detailed history of Portside Wealth Group, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Portside Wealth Group, LLC holds 6,731 shares of AZN stock, worth $559,144. This represents 0.1% of its overall portfolio holdings.
Number of Shares
6,731
Previous 5,651
19.11%
Holding current value
$559,144
Previous $383 Million
37.11%
% of portfolio
0.1%
Previous 0.07%
Shares
5 transactions
Others Institutions Holding AZN
# of Institutions
1,331Shares Held
490MCall Options Held
4.99MPut Options Held
3.19M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$5.39 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.54 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$3.37 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$3.05 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.46 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $257B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...